Speaker: Mitchell L. Shiffman, MD
Join us for an informative presentation about the latest advances in primary biliary cholangitis (PBC). Learn about an approved treatment for patients with an inadequate response to ursodeoxycholic acid (UDCA).
This program is provided by Intercept Pharmaceuticals, Inc.
Open to all WCOG at ACG2017 attendees, Exhibitor Theater presentations provide additional educational opportunities for attendees. No CME is provided for Theater presentations. All presentations will be held in the Exhibit Hall.
The asset you are trying to access is locked. Please enter your access key to unlock.